XML 30 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
Segment Information
 9 Months Ended
Sep. 30, 2016
Segment Reporting [Abstract]  
Segment Information
SEGMENT INFORMATION
The following table is a summary of our results of operations by reportable segment.
 
Three Months
 
Nine Months
 
2016
2015
 
2016
2015
Orthopaedics
$
1,077

$
1,019

 
$
3,216

$
3,077

MedSurg
1,253

943

 
3,469

2,809

Neurotechnology and Spine
503

458

 
1,483

1,345

Net sales
$
2,833

$
2,420

 
$
8,168

$
7,231

Orthopaedics
$
385

$
370

 
$
1,105

$
1,041

MedSurg
255

198

 
706

574

Neurotechnology and Spine
156

113

 
455

342

Segment operating income
$
796

$
681

 
$
2,266

$
1,957

Items not allocated to segments:
 
 
 
 
 
Corporate and other
(90
)
(76
)
 
(252
)
(220
)
Acquisition and integration-related charges
(49
)
(1
)
 
(120
)
(31
)
Amortization of intangible assets
(89
)
(54
)
 
(230
)
(152
)
Restructuring-related charges
(25
)
(22
)
 
(67
)
(78
)
Rejuvenate and ABG II and other recalls
(57
)
(150
)
 
(104
)
(316
)
Legal matters
—

—

 
12

53

Total operating income
$
486

$
378

 
$
1,505

$
1,213


Total assets of our MedSurg segment increased to $8,724 as a result of our recent acquisitions as discussed in Note 5. There were no other significant changes to total assets by segment from information provided in our Annual Report on Form 10-K for 2015.